Skip to main content
Advertisement

Main menu

  • Home
  • Articles
    • Current Issue
    • Fast Forward
    • Latest Articles
    • Special Sections
    • Archive
  • Information
    • Instructions to Authors
    • Submit a Manuscript
    • FAQs
    • For Subscribers
    • Terms & Conditions of Use
    • Permissions
  • Editorial Board
  • Alerts
    • Alerts
    • RSS Feeds
  • Virtual Issues
  • Feedback
  • Submit
  • Other Publications
    • Drug Metabolism and Disposition
    • Journal of Pharmacology and Experimental Therapeutics
    • Molecular Pharmacology
    • Pharmacological Reviews
    • Pharmacology Research & Perspectives
    • ASPET

User menu

  • My alerts
  • Log in
  • My Cart

Search

  • Advanced search
Molecular Pharmacology
  • Other Publications
    • Drug Metabolism and Disposition
    • Journal of Pharmacology and Experimental Therapeutics
    • Molecular Pharmacology
    • Pharmacological Reviews
    • Pharmacology Research & Perspectives
    • ASPET
  • My alerts
  • Log in
  • My Cart
Molecular Pharmacology

Advanced Search

  • Home
  • Articles
    • Current Issue
    • Fast Forward
    • Latest Articles
    • Special Sections
    • Archive
  • Information
    • Instructions to Authors
    • Submit a Manuscript
    • FAQs
    • For Subscribers
    • Terms & Conditions of Use
    • Permissions
  • Editorial Board
  • Alerts
    • Alerts
    • RSS Feeds
  • Virtual Issues
  • Feedback
  • Submit
  • Visit molpharm on Facebook
  • Follow molpharm on Twitter
  • Follow molpharm on LinkedIn

Index by author

August 01, 1995; Volume 48,Issue 2
  • A
  • B
  • C
  • D
  • E
  • F
  • G
  • H
  • I
  • J
  • K
  • L
  • M
  • N
  • O
  • P
  • Q
  • R
  • S
  • T
  • U
  • V
  • W
  • X
  • Y
  • Z

A

  1. Allegra, C J

    1. You have access
      Determinants of sensitivity to 1-beta-D-arabinofuranosylcytosine in HCT 116 and NCI-H630 human colon carcinoma cells.
      J L Grem, F Geoffroy, P M Politi, D P Cuddy, D D Ross, D Nguyen, S M Steinberg and C J Allegra
      Molecular Pharmacology August 1995, 48 (2) 305-315;
  2. Andis, S L

    1. You have access
      Substrate specificity of mammalian folylpolyglutamate synthetase for 5,10-dideazatetrahydrofolate analogs.
      L L Habeck, L G Mendelsohn, C Shih, E C Taylor, P D Colman, L S Gossett, T A Leitner, R M Schultz, S L Andis and R G Moran
      Molecular Pharmacology August 1995, 48 (2) 326-333;
  3. Arthur, J M

    1. You have access
      5-Hydroxytryptamine2A receptors expressed in rat renal mesangial cells inhibit cyclic AMP accumulation.
      M N Garnovskaya, C G Nebigil, J M Arthur, R F Spurney and J R Raymond
      Molecular Pharmacology August 1995, 48 (2) 230-237;

B

  1. Backstrom, J R

    1. You have access
      Increased basal phosphorylation of the constitutively active serotonin 2C receptor accompanies agonist-mediated desensitization.
      R S Westphal, J R Backstrom and E Sanders-Bush
      Molecular Pharmacology August 1995, 48 (2) 200-205;
  2. Barker, J L

    1. You have access
      The low efficacy gamma-aminobutyric acid type A agonist 5-(4-piperidyl)isoxazol-3-ol opens brief Cl- channels in embryonic rat olfactory bulb neurons.
      U Kristiansen, J L Barker and R Serafini
      Molecular Pharmacology August 1995, 48 (2) 268-279;
  3. Birdsall, N J

    1. You have access
      Detection, quantitation, and verification of allosteric interactions of agents with labeled and unlabeled ligands at G protein-coupled receptors: interactions of strychnine and acetylcholine at muscarinic receptors.
      S Lazareno and N J Birdsall
      Molecular Pharmacology August 1995, 48 (2) 362-378;
  4. Boulton, C L

    1. You have access
      Potent and selective inhibition of nitric oxide-sensitive guanylyl cyclase by 1H-[1,2,4]oxadiazolo[4,3-a]quinoxalin-1-one.
      J Garthwaite, E Southam, C L Boulton, E B Nielsen, K Schmidt and B Mayer
      Molecular Pharmacology August 1995, 48 (2) 184-188;
  5. Briley, E M

    1. You have access
      Mead ethanolamide, a novel eicosanoid, is an agonist for the central (CB1) and peripheral (CB2) cannabinoid receptors.
      J Priller, E M Briley, J Mansouri, W A Devane, K Mackie and C C Felder
      Molecular Pharmacology August 1995, 48 (2) 288-292;
  6. Buell, G

    1. You have access
      Pharmacological characterization of heterologously expressed ATP-gated cation channels (P2x purinoceptors).
      R J Evans, C Lewis, G Buell, S Valera, R A North and A Surprenant
      Molecular Pharmacology August 1995, 48 (2) 178-183;

C

  1. Cai, J

    1. You have access
      Hormonal and cell density regulation of hepatic gamma-glutamylcysteine synthetase gene expression.
      J Cai, W M Sun and S C Lu
      Molecular Pharmacology August 1995, 48 (2) 212-218;
  2. Chapman, R S

    1. You have access
      Characterization of drug resistance mediated via the suppression of apoptosis by Abelson protein tyrosine kinase.
      R S Chapman, A D Whetton, C M Chresta and C Dive
      Molecular Pharmacology August 1995, 48 (2) 334-343;
  3. Chresta, C M

    1. You have access
      Characterization of drug resistance mediated via the suppression of apoptosis by Abelson protein tyrosine kinase.
      R S Chapman, A D Whetton, C M Chresta and C Dive
      Molecular Pharmacology August 1995, 48 (2) 334-343;
  4. Chung, I K

    1. You have access
      Analysis of eukaryotic topoisomerase II cleavage sites in the presence of the quinolone CP-115,953 reveals drug-dependent and -independent recognition elements.
      J R Spitzner, I K Chung, T D Gootz, P R McGuirk and M T Muller
      Molecular Pharmacology August 1995, 48 (2) 238-249;
  5. Colman, P D

    1. You have access
      Substrate specificity of mammalian folylpolyglutamate synthetase for 5,10-dideazatetrahydrofolate analogs.
      L L Habeck, L G Mendelsohn, C Shih, E C Taylor, P D Colman, L S Gossett, T A Leitner, R M Schultz, S L Andis and R G Moran
      Molecular Pharmacology August 1995, 48 (2) 326-333;
  6. Côté, T E

    1. You have access
      Antisense oligodeoxynucleotide to the Gi2 protein alpha subunit sequence inhibits an opioid-induced increase in the intracellular free calcium concentration in ND8-47 neuroblastoma x dorsal root ganglion hybrid cells.
      T Tang, J G Kiang, T E Côté and B M Cox
      Molecular Pharmacology August 1995, 48 (2) 189-193;
  7. Cox, B M

    1. You have access
      Antisense oligodeoxynucleotide to the Gi2 protein alpha subunit sequence inhibits an opioid-induced increase in the intracellular free calcium concentration in ND8-47 neuroblastoma x dorsal root ganglion hybrid cells.
      T Tang, J G Kiang, T E Côté and B M Cox
      Molecular Pharmacology August 1995, 48 (2) 189-193;
  8. Cuddy, D P

    1. You have access
      Determinants of sensitivity to 1-beta-D-arabinofuranosylcytosine in HCT 116 and NCI-H630 human colon carcinoma cells.
      J L Grem, F Geoffroy, P M Politi, D P Cuddy, D D Ross, D Nguyen, S M Steinberg and C J Allegra
      Molecular Pharmacology August 1995, 48 (2) 305-315;

D

  1. Dávila-García, M I

    1. You have access
      Characterization of (+/-)(-)[3H]epibatidine binding to nicotinic cholinergic receptors in rat and human brain.
      R A Houghtling, M I Dávila-García and K J Kellar
      Molecular Pharmacology August 1995, 48 (2) 280-287;
  2. Devane, W A

    1. You have access
      Mead ethanolamide, a novel eicosanoid, is an agonist for the central (CB1) and peripheral (CB2) cannabinoid receptors.
      J Priller, E M Briley, J Mansouri, W A Devane, K Mackie and C C Felder
      Molecular Pharmacology August 1995, 48 (2) 288-292;
  3. Dimitrijević, S M

    1. You have access
      Characterization of phorbol ester binding to protein kinase C isotypes.
      S M Dimitrijević, W J Ryves, P J Parker and F J Evans
      Molecular Pharmacology August 1995, 48 (2) 259-267;
  4. Dive, C

    1. You have access
      Characterization of drug resistance mediated via the suppression of apoptosis by Abelson protein tyrosine kinase.
      R S Chapman, A D Whetton, C M Chresta and C Dive
      Molecular Pharmacology August 1995, 48 (2) 334-343;
  5. Dufresne, C

    1. You have access
      Activation of the human peripheral cannabinoid receptor results in inhibition of adenylyl cyclase.
      D M Slipetz, G P O'Neill, L Favreau, C Dufresne, M Gallant, Y Gareau, D Guay, M Labelle and K M Metters
      Molecular Pharmacology August 1995, 48 (2) 352-361;
  6. Duman, R S

    1. You have access
      Regulation of beta 2-adrenergic receptor mRNA and gene transcription in rat C6 glioma cells: effects of agonist, forskolin, and protein synthesis inhibition.
      K Hosoda, L R Fitzgerald, V A Vaidya, G K Feussner, P H Fishman and R S Duman
      Molecular Pharmacology August 1995, 48 (2) 206-211;

E

  1. Eisenstein, J

    1. You have access
      Characterization of a chimeric human dopamine D3/D2 receptor functionally coupled to adenylyl cyclase in Chinese hamster ovary cells.
      D H Van Leeuwen, J Eisenstein, K O'Malley and R G MacKenzie
      Molecular Pharmacology August 1995, 48 (2) 344-351;
  2. Elgoyhen, A B

    1. You have access
      alpha-Conotoxin ImI exhibits subtype-specific nicotinic acetylcholine receptor blockade: preferential inhibition of homomeric alpha 7 and alpha 9 receptors.
      D S Johnson, J Martinez, A B Elgoyhen, S F Heinemann and J M McIntosh
      Molecular Pharmacology August 1995, 48 (2) 194-199;
  3. Evans, F J

    1. You have access
      Characterization of phorbol ester binding to protein kinase C isotypes.
      S M Dimitrijević, W J Ryves, P J Parker and F J Evans
      Molecular Pharmacology August 1995, 48 (2) 259-267;
  4. Evans, R J

    1. You have access
      Pharmacological characterization of heterologously expressed ATP-gated cation channels (P2x purinoceptors).
      R J Evans, C Lewis, G Buell, S Valera, R A North and A Surprenant
      Molecular Pharmacology August 1995, 48 (2) 178-183;

F

  1. Favreau, L

    1. You have access
      Activation of the human peripheral cannabinoid receptor results in inhibition of adenylyl cyclase.
      D M Slipetz, G P O'Neill, L Favreau, C Dufresne, M Gallant, Y Gareau, D Guay, M Labelle and K M Metters
      Molecular Pharmacology August 1995, 48 (2) 352-361;
  2. Felder, C C

    1. You have access
      Mead ethanolamide, a novel eicosanoid, is an agonist for the central (CB1) and peripheral (CB2) cannabinoid receptors.
      J Priller, E M Briley, J Mansouri, W A Devane, K Mackie and C C Felder
      Molecular Pharmacology August 1995, 48 (2) 288-292;
  3. Feussner, G K

    1. You have access
      Regulation of beta 2-adrenergic receptor mRNA and gene transcription in rat C6 glioma cells: effects of agonist, forskolin, and protein synthesis inhibition.
      K Hosoda, L R Fitzgerald, V A Vaidya, G K Feussner, P H Fishman and R S Duman
      Molecular Pharmacology August 1995, 48 (2) 206-211;
  4. Fishman, P H

    1. You have access
      Regulation of beta 2-adrenergic receptor mRNA and gene transcription in rat C6 glioma cells: effects of agonist, forskolin, and protein synthesis inhibition.
      K Hosoda, L R Fitzgerald, V A Vaidya, G K Feussner, P H Fishman and R S Duman
      Molecular Pharmacology August 1995, 48 (2) 206-211;
  5. Fitzgerald, L R

    1. You have access
      Regulation of beta 2-adrenergic receptor mRNA and gene transcription in rat C6 glioma cells: effects of agonist, forskolin, and protein synthesis inhibition.
      K Hosoda, L R Fitzgerald, V A Vaidya, G K Feussner, P H Fishman and R S Duman
      Molecular Pharmacology August 1995, 48 (2) 206-211;
  6. Foglar, R

    1. You have access
      KMD-3213, a novel, potent, alpha 1a-adrenoceptor-selective antagonist: characterization using recombinant human alpha 1-adrenoceptors and native tissues.
      K Shibata, R Foglar, K Horie, K Obika, A Sakamoto, S Ogawa and G Tsujimoto
      Molecular Pharmacology August 1995, 48 (2) 250-258;
  7. Freedman, N J

    1. You have access
      Agonist-dependent phosphorylation of the mouse delta-opioid receptor: involvement of G protein-coupled receptor kinases but not protein kinase C.
      G Pei, B L Kieffer, R J Lefkowitz and N J Freedman
      Molecular Pharmacology August 1995, 48 (2) 173-177;
  8. Fremeau, R T

    1. You have access
      Human brain-specific L-proline transporter: molecular cloning, functional expression, and chromosomal localization of the gene in human and mouse genomes.
      S Shafqat, M Velaz-Faircloth, V A Henzi, K D Whitney, T L Yang-Feng, M F Seldin and R T Fremeau
      Molecular Pharmacology August 1995, 48 (2) 219-229;

G

  1. Gallant, M

    1. You have access
      Activation of the human peripheral cannabinoid receptor results in inhibition of adenylyl cyclase.
      D M Slipetz, G P O'Neill, L Favreau, C Dufresne, M Gallant, Y Gareau, D Guay, M Labelle and K M Metters
      Molecular Pharmacology August 1995, 48 (2) 352-361;
  2. Gareau, Y

    1. You have access
      Activation of the human peripheral cannabinoid receptor results in inhibition of adenylyl cyclase.
      D M Slipetz, G P O'Neill, L Favreau, C Dufresne, M Gallant, Y Gareau, D Guay, M Labelle and K M Metters
      Molecular Pharmacology August 1995, 48 (2) 352-361;
  3. Garnovskaya, M N

    1. You have access
      5-Hydroxytryptamine2A receptors expressed in rat renal mesangial cells inhibit cyclic AMP accumulation.
      M N Garnovskaya, C G Nebigil, J M Arthur, R F Spurney and J R Raymond
      Molecular Pharmacology August 1995, 48 (2) 230-237;
  4. Garthwaite, J

    1. You have access
      Potent and selective inhibition of nitric oxide-sensitive guanylyl cyclase by 1H-[1,2,4]oxadiazolo[4,3-a]quinoxalin-1-one.
      J Garthwaite, E Southam, C L Boulton, E B Nielsen, K Schmidt and B Mayer
      Molecular Pharmacology August 1995, 48 (2) 184-188;
  5. Geoffroy, F

    1. You have access
      Determinants of sensitivity to 1-beta-D-arabinofuranosylcytosine in HCT 116 and NCI-H630 human colon carcinoma cells.
      J L Grem, F Geoffroy, P M Politi, D P Cuddy, D D Ross, D Nguyen, S M Steinberg and C J Allegra
      Molecular Pharmacology August 1995, 48 (2) 305-315;
  6. Gootz, T D

    1. You have access
      Analysis of eukaryotic topoisomerase II cleavage sites in the presence of the quinolone CP-115,953 reveals drug-dependent and -independent recognition elements.
      J R Spitzner, I K Chung, T D Gootz, P R McGuirk and M T Muller
      Molecular Pharmacology August 1995, 48 (2) 238-249;
  7. Gossett, L S

    1. You have access
      Substrate specificity of mammalian folylpolyglutamate synthetase for 5,10-dideazatetrahydrofolate analogs.
      L L Habeck, L G Mendelsohn, C Shih, E C Taylor, P D Colman, L S Gossett, T A Leitner, R M Schultz, S L Andis and R G Moran
      Molecular Pharmacology August 1995, 48 (2) 326-333;
  8. Grem, J L

    1. You have access
      Determinants of sensitivity to 1-beta-D-arabinofuranosylcytosine in HCT 116 and NCI-H630 human colon carcinoma cells.
      J L Grem, F Geoffroy, P M Politi, D P Cuddy, D D Ross, D Nguyen, S M Steinberg and C J Allegra
      Molecular Pharmacology August 1995, 48 (2) 305-315;
  9. Guay, D

    1. You have access
      Activation of the human peripheral cannabinoid receptor results in inhibition of adenylyl cyclase.
      D M Slipetz, G P O'Neill, L Favreau, C Dufresne, M Gallant, Y Gareau, D Guay, M Labelle and K M Metters
      Molecular Pharmacology August 1995, 48 (2) 352-361;

H

  1. Habeck, L L

    1. You have access
      Substrate specificity of mammalian folylpolyglutamate synthetase for 5,10-dideazatetrahydrofolate analogs.
      L L Habeck, L G Mendelsohn, C Shih, E C Taylor, P D Colman, L S Gossett, T A Leitner, R M Schultz, S L Andis and R G Moran
      Molecular Pharmacology August 1995, 48 (2) 326-333;
  2. Heinemann, S F

    1. You have access
      alpha-Conotoxin ImI exhibits subtype-specific nicotinic acetylcholine receptor blockade: preferential inhibition of homomeric alpha 7 and alpha 9 receptors.
      D S Johnson, J Martinez, A B Elgoyhen, S F Heinemann and J M McIntosh
      Molecular Pharmacology August 1995, 48 (2) 194-199;
  3. Henzi, V A

    1. You have access
      Human brain-specific L-proline transporter: molecular cloning, functional expression, and chromosomal localization of the gene in human and mouse genomes.
      S Shafqat, M Velaz-Faircloth, V A Henzi, K D Whitney, T L Yang-Feng, M F Seldin and R T Fremeau
      Molecular Pharmacology August 1995, 48 (2) 219-229;
  4. Horie, K

    1. You have access
      KMD-3213, a novel, potent, alpha 1a-adrenoceptor-selective antagonist: characterization using recombinant human alpha 1-adrenoceptors and native tissues.
      K Shibata, R Foglar, K Horie, K Obika, A Sakamoto, S Ogawa and G Tsujimoto
      Molecular Pharmacology August 1995, 48 (2) 250-258;
  5. Hosoda, K

    1. You have access
      Regulation of beta 2-adrenergic receptor mRNA and gene transcription in rat C6 glioma cells: effects of agonist, forskolin, and protein synthesis inhibition.
      K Hosoda, L R Fitzgerald, V A Vaidya, G K Feussner, P H Fishman and R S Duman
      Molecular Pharmacology August 1995, 48 (2) 206-211;
  6. Houghtling, R A

    1. You have access
      Characterization of (+/-)(-)[3H]epibatidine binding to nicotinic cholinergic receptors in rat and human brain.
      R A Houghtling, M I Dávila-García and K J Kellar
      Molecular Pharmacology August 1995, 48 (2) 280-287;

J

  1. Johnson, D S

    1. You have access
      alpha-Conotoxin ImI exhibits subtype-specific nicotinic acetylcholine receptor blockade: preferential inhibition of homomeric alpha 7 and alpha 9 receptors.
      D S Johnson, J Martinez, A B Elgoyhen, S F Heinemann and J M McIntosh
      Molecular Pharmacology August 1995, 48 (2) 194-199;

K

  1. Kellar, K J

    1. You have access
      Characterization of (+/-)(-)[3H]epibatidine binding to nicotinic cholinergic receptors in rat and human brain.
      R A Houghtling, M I Dávila-García and K J Kellar
      Molecular Pharmacology August 1995, 48 (2) 280-287;
  2. Kiang, J G

    1. You have access
      Antisense oligodeoxynucleotide to the Gi2 protein alpha subunit sequence inhibits an opioid-induced increase in the intracellular free calcium concentration in ND8-47 neuroblastoma x dorsal root ganglion hybrid cells.
      T Tang, J G Kiang, T E Côté and B M Cox
      Molecular Pharmacology August 1995, 48 (2) 189-193;
  3. Kieffer, B L

    1. You have access
      Agonist-dependent phosphorylation of the mouse delta-opioid receptor: involvement of G protein-coupled receptor kinases but not protein kinase C.
      G Pei, B L Kieffer, R J Lefkowitz and N J Freedman
      Molecular Pharmacology August 1995, 48 (2) 173-177;
  4. Kim, G D

    1. You have access
      Analysis of the role of receptor number in defining the intrinsic activity and potency of partial agonists in neuroblastoma x glioma hybrid NG108-15 cells transfected to express differing levels of the human beta 2-adrenoceptor.
      D J MacEwan, G D Kim and G Milligan
      Molecular Pharmacology August 1995, 48 (2) 316-325;
  5. Kristiansen, U

    1. You have access
      The low efficacy gamma-aminobutyric acid type A agonist 5-(4-piperidyl)isoxazol-3-ol opens brief Cl- channels in embryonic rat olfactory bulb neurons.
      U Kristiansen, J L Barker and R Serafini
      Molecular Pharmacology August 1995, 48 (2) 268-279;

L

  1. Labelle, M

    1. You have access
      Activation of the human peripheral cannabinoid receptor results in inhibition of adenylyl cyclase.
      D M Slipetz, G P O'Neill, L Favreau, C Dufresne, M Gallant, Y Gareau, D Guay, M Labelle and K M Metters
      Molecular Pharmacology August 1995, 48 (2) 352-361;
  2. Lazareno, S

    1. You have access
      Detection, quantitation, and verification of allosteric interactions of agents with labeled and unlabeled ligands at G protein-coupled receptors: interactions of strychnine and acetylcholine at muscarinic receptors.
      S Lazareno and N J Birdsall
      Molecular Pharmacology August 1995, 48 (2) 362-378;
  3. Lefkowitz, R J

    1. You have access
      Agonist-dependent phosphorylation of the mouse delta-opioid receptor: involvement of G protein-coupled receptor kinases but not protein kinase C.
      G Pei, B L Kieffer, R J Lefkowitz and N J Freedman
      Molecular Pharmacology August 1995, 48 (2) 173-177;
  4. Leitner, T A

    1. You have access
      Substrate specificity of mammalian folylpolyglutamate synthetase for 5,10-dideazatetrahydrofolate analogs.
      L L Habeck, L G Mendelsohn, C Shih, E C Taylor, P D Colman, L S Gossett, T A Leitner, R M Schultz, S L Andis and R G Moran
      Molecular Pharmacology August 1995, 48 (2) 326-333;
  5. Lewis, C

    1. You have access
      Pharmacological characterization of heterologously expressed ATP-gated cation channels (P2x purinoceptors).
      R J Evans, C Lewis, G Buell, S Valera, R A North and A Surprenant
      Molecular Pharmacology August 1995, 48 (2) 178-183;
  6. Lu, S C

    1. You have access
      Hormonal and cell density regulation of hepatic gamma-glutamylcysteine synthetase gene expression.
      J Cai, W M Sun and S C Lu
      Molecular Pharmacology August 1995, 48 (2) 212-218;

M

  1. MacEwan, D J

    1. You have access
      Analysis of the role of receptor number in defining the intrinsic activity and potency of partial agonists in neuroblastoma x glioma hybrid NG108-15 cells transfected to express differing levels of the human beta 2-adrenoceptor.
      D J MacEwan, G D Kim and G Milligan
      Molecular Pharmacology August 1995, 48 (2) 316-325;
  2. MacKenzie, R G

    1. You have access
      Characterization of a chimeric human dopamine D3/D2 receptor functionally coupled to adenylyl cyclase in Chinese hamster ovary cells.
      D H Van Leeuwen, J Eisenstein, K O'Malley and R G MacKenzie
      Molecular Pharmacology August 1995, 48 (2) 344-351;
  3. Mackie, K

    1. You have access
      Mead ethanolamide, a novel eicosanoid, is an agonist for the central (CB1) and peripheral (CB2) cannabinoid receptors.
      J Priller, E M Briley, J Mansouri, W A Devane, K Mackie and C C Felder
      Molecular Pharmacology August 1995, 48 (2) 288-292;
  4. Makhlouf, G M

    1. You have access
      Agonist-mediated activation of phosphatidylcholine-specific phospholipase C and D in intestinal smooth muscle.
      K S Murthy and G M Makhlouf
      Molecular Pharmacology August 1995, 48 (2) 293-304;
  5. Mansouri, J

    1. You have access
      Mead ethanolamide, a novel eicosanoid, is an agonist for the central (CB1) and peripheral (CB2) cannabinoid receptors.
      J Priller, E M Briley, J Mansouri, W A Devane, K Mackie and C C Felder
      Molecular Pharmacology August 1995, 48 (2) 288-292;
  6. Martinez, J

    1. You have access
      alpha-Conotoxin ImI exhibits subtype-specific nicotinic acetylcholine receptor blockade: preferential inhibition of homomeric alpha 7 and alpha 9 receptors.
      D S Johnson, J Martinez, A B Elgoyhen, S F Heinemann and J M McIntosh
      Molecular Pharmacology August 1995, 48 (2) 194-199;
  7. Mayer, B

    1. You have access
      Potent and selective inhibition of nitric oxide-sensitive guanylyl cyclase by 1H-[1,2,4]oxadiazolo[4,3-a]quinoxalin-1-one.
      J Garthwaite, E Southam, C L Boulton, E B Nielsen, K Schmidt and B Mayer
      Molecular Pharmacology August 1995, 48 (2) 184-188;
  8. McGuirk, P R

    1. You have access
      Analysis of eukaryotic topoisomerase II cleavage sites in the presence of the quinolone CP-115,953 reveals drug-dependent and -independent recognition elements.
      J R Spitzner, I K Chung, T D Gootz, P R McGuirk and M T Muller
      Molecular Pharmacology August 1995, 48 (2) 238-249;
  9. McIntosh, J M

    1. You have access
      alpha-Conotoxin ImI exhibits subtype-specific nicotinic acetylcholine receptor blockade: preferential inhibition of homomeric alpha 7 and alpha 9 receptors.
      D S Johnson, J Martinez, A B Elgoyhen, S F Heinemann and J M McIntosh
      Molecular Pharmacology August 1995, 48 (2) 194-199;
  10. Mendelsohn, L G

    1. You have access
      Substrate specificity of mammalian folylpolyglutamate synthetase for 5,10-dideazatetrahydrofolate analogs.
      L L Habeck, L G Mendelsohn, C Shih, E C Taylor, P D Colman, L S Gossett, T A Leitner, R M Schultz, S L Andis and R G Moran
      Molecular Pharmacology August 1995, 48 (2) 326-333;
  11. Metters, K M

    1. You have access
      Activation of the human peripheral cannabinoid receptor results in inhibition of adenylyl cyclase.
      D M Slipetz, G P O'Neill, L Favreau, C Dufresne, M Gallant, Y Gareau, D Guay, M Labelle and K M Metters
      Molecular Pharmacology August 1995, 48 (2) 352-361;
  12. Milligan, G

    1. You have access
      Analysis of the role of receptor number in defining the intrinsic activity and potency of partial agonists in neuroblastoma x glioma hybrid NG108-15 cells transfected to express differing levels of the human beta 2-adrenoceptor.
      D J MacEwan, G D Kim and G Milligan
      Molecular Pharmacology August 1995, 48 (2) 316-325;
  13. Moran, R G

    1. You have access
      Substrate specificity of mammalian folylpolyglutamate synthetase for 5,10-dideazatetrahydrofolate analogs.
      L L Habeck, L G Mendelsohn, C Shih, E C Taylor, P D Colman, L S Gossett, T A Leitner, R M Schultz, S L Andis and R G Moran
      Molecular Pharmacology August 1995, 48 (2) 326-333;
  14. Muller, M T

    1. You have access
      Analysis of eukaryotic topoisomerase II cleavage sites in the presence of the quinolone CP-115,953 reveals drug-dependent and -independent recognition elements.
      J R Spitzner, I K Chung, T D Gootz, P R McGuirk and M T Muller
      Molecular Pharmacology August 1995, 48 (2) 238-249;
  15. Murthy, K S

    1. You have access
      Agonist-mediated activation of phosphatidylcholine-specific phospholipase C and D in intestinal smooth muscle.
      K S Murthy and G M Makhlouf
      Molecular Pharmacology August 1995, 48 (2) 293-304;

N

  1. Nebigil, C G

    1. You have access
      5-Hydroxytryptamine2A receptors expressed in rat renal mesangial cells inhibit cyclic AMP accumulation.
      M N Garnovskaya, C G Nebigil, J M Arthur, R F Spurney and J R Raymond
      Molecular Pharmacology August 1995, 48 (2) 230-237;
  2. Nguyen, D

    1. You have access
      Determinants of sensitivity to 1-beta-D-arabinofuranosylcytosine in HCT 116 and NCI-H630 human colon carcinoma cells.
      J L Grem, F Geoffroy, P M Politi, D P Cuddy, D D Ross, D Nguyen, S M Steinberg and C J Allegra
      Molecular Pharmacology August 1995, 48 (2) 305-315;
  3. Nielsen, E B

    1. You have access
      Potent and selective inhibition of nitric oxide-sensitive guanylyl cyclase by 1H-[1,2,4]oxadiazolo[4,3-a]quinoxalin-1-one.
      J Garthwaite, E Southam, C L Boulton, E B Nielsen, K Schmidt and B Mayer
      Molecular Pharmacology August 1995, 48 (2) 184-188;
  4. North, R A

    1. You have access
      Pharmacological characterization of heterologously expressed ATP-gated cation channels (P2x purinoceptors).
      R J Evans, C Lewis, G Buell, S Valera, R A North and A Surprenant
      Molecular Pharmacology August 1995, 48 (2) 178-183;

O

  1. O'Malley, K

    1. You have access
      Characterization of a chimeric human dopamine D3/D2 receptor functionally coupled to adenylyl cyclase in Chinese hamster ovary cells.
      D H Van Leeuwen, J Eisenstein, K O'Malley and R G MacKenzie
      Molecular Pharmacology August 1995, 48 (2) 344-351;
  2. O'Neill, G P

    1. You have access
      Activation of the human peripheral cannabinoid receptor results in inhibition of adenylyl cyclase.
      D M Slipetz, G P O'Neill, L Favreau, C Dufresne, M Gallant, Y Gareau, D Guay, M Labelle and K M Metters
      Molecular Pharmacology August 1995, 48 (2) 352-361;
  3. Obika, K

    1. You have access
      KMD-3213, a novel, potent, alpha 1a-adrenoceptor-selective antagonist: characterization using recombinant human alpha 1-adrenoceptors and native tissues.
      K Shibata, R Foglar, K Horie, K Obika, A Sakamoto, S Ogawa and G Tsujimoto
      Molecular Pharmacology August 1995, 48 (2) 250-258;
  4. Ogawa, S

    1. You have access
      KMD-3213, a novel, potent, alpha 1a-adrenoceptor-selective antagonist: characterization using recombinant human alpha 1-adrenoceptors and native tissues.
      K Shibata, R Foglar, K Horie, K Obika, A Sakamoto, S Ogawa and G Tsujimoto
      Molecular Pharmacology August 1995, 48 (2) 250-258;

P

  1. Parker, P J

    1. You have access
      Characterization of phorbol ester binding to protein kinase C isotypes.
      S M Dimitrijević, W J Ryves, P J Parker and F J Evans
      Molecular Pharmacology August 1995, 48 (2) 259-267;
  2. Pei, G

    1. You have access
      Agonist-dependent phosphorylation of the mouse delta-opioid receptor: involvement of G protein-coupled receptor kinases but not protein kinase C.
      G Pei, B L Kieffer, R J Lefkowitz and N J Freedman
      Molecular Pharmacology August 1995, 48 (2) 173-177;
  3. Politi, P M

    1. You have access
      Determinants of sensitivity to 1-beta-D-arabinofuranosylcytosine in HCT 116 and NCI-H630 human colon carcinoma cells.
      J L Grem, F Geoffroy, P M Politi, D P Cuddy, D D Ross, D Nguyen, S M Steinberg and C J Allegra
      Molecular Pharmacology August 1995, 48 (2) 305-315;
  4. Priller, J

    1. You have access
      Mead ethanolamide, a novel eicosanoid, is an agonist for the central (CB1) and peripheral (CB2) cannabinoid receptors.
      J Priller, E M Briley, J Mansouri, W A Devane, K Mackie and C C Felder
      Molecular Pharmacology August 1995, 48 (2) 288-292;

R

  1. Raymond, J R

    1. You have access
      5-Hydroxytryptamine2A receptors expressed in rat renal mesangial cells inhibit cyclic AMP accumulation.
      M N Garnovskaya, C G Nebigil, J M Arthur, R F Spurney and J R Raymond
      Molecular Pharmacology August 1995, 48 (2) 230-237;
  2. Ross, D D

    1. You have access
      Determinants of sensitivity to 1-beta-D-arabinofuranosylcytosine in HCT 116 and NCI-H630 human colon carcinoma cells.
      J L Grem, F Geoffroy, P M Politi, D P Cuddy, D D Ross, D Nguyen, S M Steinberg and C J Allegra
      Molecular Pharmacology August 1995, 48 (2) 305-315;
  3. Ryves, W J

    1. You have access
      Characterization of phorbol ester binding to protein kinase C isotypes.
      S M Dimitrijević, W J Ryves, P J Parker and F J Evans
      Molecular Pharmacology August 1995, 48 (2) 259-267;

S

  1. Sakamoto, A

    1. You have access
      KMD-3213, a novel, potent, alpha 1a-adrenoceptor-selective antagonist: characterization using recombinant human alpha 1-adrenoceptors and native tissues.
      K Shibata, R Foglar, K Horie, K Obika, A Sakamoto, S Ogawa and G Tsujimoto
      Molecular Pharmacology August 1995, 48 (2) 250-258;
  2. Sanders-Bush, E

    1. You have access
      Increased basal phosphorylation of the constitutively active serotonin 2C receptor accompanies agonist-mediated desensitization.
      R S Westphal, J R Backstrom and E Sanders-Bush
      Molecular Pharmacology August 1995, 48 (2) 200-205;
  3. Schmidt, K

    1. You have access
      Potent and selective inhibition of nitric oxide-sensitive guanylyl cyclase by 1H-[1,2,4]oxadiazolo[4,3-a]quinoxalin-1-one.
      J Garthwaite, E Southam, C L Boulton, E B Nielsen, K Schmidt and B Mayer
      Molecular Pharmacology August 1995, 48 (2) 184-188;
  4. Schultz, R M

    1. You have access
      Substrate specificity of mammalian folylpolyglutamate synthetase for 5,10-dideazatetrahydrofolate analogs.
      L L Habeck, L G Mendelsohn, C Shih, E C Taylor, P D Colman, L S Gossett, T A Leitner, R M Schultz, S L Andis and R G Moran
      Molecular Pharmacology August 1995, 48 (2) 326-333;
  5. Seldin, M F

    1. You have access
      Human brain-specific L-proline transporter: molecular cloning, functional expression, and chromosomal localization of the gene in human and mouse genomes.
      S Shafqat, M Velaz-Faircloth, V A Henzi, K D Whitney, T L Yang-Feng, M F Seldin and R T Fremeau
      Molecular Pharmacology August 1995, 48 (2) 219-229;
  6. Serafini, R

    1. You have access
      The low efficacy gamma-aminobutyric acid type A agonist 5-(4-piperidyl)isoxazol-3-ol opens brief Cl- channels in embryonic rat olfactory bulb neurons.
      U Kristiansen, J L Barker and R Serafini
      Molecular Pharmacology August 1995, 48 (2) 268-279;
  7. Shafqat, S

    1. You have access
      Human brain-specific L-proline transporter: molecular cloning, functional expression, and chromosomal localization of the gene in human and mouse genomes.
      S Shafqat, M Velaz-Faircloth, V A Henzi, K D Whitney, T L Yang-Feng, M F Seldin and R T Fremeau
      Molecular Pharmacology August 1995, 48 (2) 219-229;
  8. Shibata, K

    1. You have access
      KMD-3213, a novel, potent, alpha 1a-adrenoceptor-selective antagonist: characterization using recombinant human alpha 1-adrenoceptors and native tissues.
      K Shibata, R Foglar, K Horie, K Obika, A Sakamoto, S Ogawa and G Tsujimoto
      Molecular Pharmacology August 1995, 48 (2) 250-258;
  9. Shih, C

    1. You have access
      Substrate specificity of mammalian folylpolyglutamate synthetase for 5,10-dideazatetrahydrofolate analogs.
      L L Habeck, L G Mendelsohn, C Shih, E C Taylor, P D Colman, L S Gossett, T A Leitner, R M Schultz, S L Andis and R G Moran
      Molecular Pharmacology August 1995, 48 (2) 326-333;
  10. Slipetz, D M

    1. You have access
      Activation of the human peripheral cannabinoid receptor results in inhibition of adenylyl cyclase.
      D M Slipetz, G P O'Neill, L Favreau, C Dufresne, M Gallant, Y Gareau, D Guay, M Labelle and K M Metters
      Molecular Pharmacology August 1995, 48 (2) 352-361;
  11. Southam, E

    1. You have access
      Potent and selective inhibition of nitric oxide-sensitive guanylyl cyclase by 1H-[1,2,4]oxadiazolo[4,3-a]quinoxalin-1-one.
      J Garthwaite, E Southam, C L Boulton, E B Nielsen, K Schmidt and B Mayer
      Molecular Pharmacology August 1995, 48 (2) 184-188;
  12. Spitzner, J R

    1. You have access
      Analysis of eukaryotic topoisomerase II cleavage sites in the presence of the quinolone CP-115,953 reveals drug-dependent and -independent recognition elements.
      J R Spitzner, I K Chung, T D Gootz, P R McGuirk and M T Muller
      Molecular Pharmacology August 1995, 48 (2) 238-249;
  13. Spurney, R F

    1. You have access
      5-Hydroxytryptamine2A receptors expressed in rat renal mesangial cells inhibit cyclic AMP accumulation.
      M N Garnovskaya, C G Nebigil, J M Arthur, R F Spurney and J R Raymond
      Molecular Pharmacology August 1995, 48 (2) 230-237;
  14. Steinberg, S M

    1. You have access
      Determinants of sensitivity to 1-beta-D-arabinofuranosylcytosine in HCT 116 and NCI-H630 human colon carcinoma cells.
      J L Grem, F Geoffroy, P M Politi, D P Cuddy, D D Ross, D Nguyen, S M Steinberg and C J Allegra
      Molecular Pharmacology August 1995, 48 (2) 305-315;
  15. Sun, W M

    1. You have access
      Hormonal and cell density regulation of hepatic gamma-glutamylcysteine synthetase gene expression.
      J Cai, W M Sun and S C Lu
      Molecular Pharmacology August 1995, 48 (2) 212-218;
  16. Surprenant, A

    1. You have access
      Pharmacological characterization of heterologously expressed ATP-gated cation channels (P2x purinoceptors).
      R J Evans, C Lewis, G Buell, S Valera, R A North and A Surprenant
      Molecular Pharmacology August 1995, 48 (2) 178-183;

T

  1. Tang, T

    1. You have access
      Antisense oligodeoxynucleotide to the Gi2 protein alpha subunit sequence inhibits an opioid-induced increase in the intracellular free calcium concentration in ND8-47 neuroblastoma x dorsal root ganglion hybrid cells.
      T Tang, J G Kiang, T E Côté and B M Cox
      Molecular Pharmacology August 1995, 48 (2) 189-193;
  2. Taylor, E C

    1. You have access
      Substrate specificity of mammalian folylpolyglutamate synthetase for 5,10-dideazatetrahydrofolate analogs.
      L L Habeck, L G Mendelsohn, C Shih, E C Taylor, P D Colman, L S Gossett, T A Leitner, R M Schultz, S L Andis and R G Moran
      Molecular Pharmacology August 1995, 48 (2) 326-333;
  3. Tsujimoto, G

    1. You have access
      KMD-3213, a novel, potent, alpha 1a-adrenoceptor-selective antagonist: characterization using recombinant human alpha 1-adrenoceptors and native tissues.
      K Shibata, R Foglar, K Horie, K Obika, A Sakamoto, S Ogawa and G Tsujimoto
      Molecular Pharmacology August 1995, 48 (2) 250-258;

V

  1. Vaidya, V A

    1. You have access
      Regulation of beta 2-adrenergic receptor mRNA and gene transcription in rat C6 glioma cells: effects of agonist, forskolin, and protein synthesis inhibition.
      K Hosoda, L R Fitzgerald, V A Vaidya, G K Feussner, P H Fishman and R S Duman
      Molecular Pharmacology August 1995, 48 (2) 206-211;
  2. Valera, S

    1. You have access
      Pharmacological characterization of heterologously expressed ATP-gated cation channels (P2x purinoceptors).
      R J Evans, C Lewis, G Buell, S Valera, R A North and A Surprenant
      Molecular Pharmacology August 1995, 48 (2) 178-183;
  3. Van Leeuwen, D H

    1. You have access
      Characterization of a chimeric human dopamine D3/D2 receptor functionally coupled to adenylyl cyclase in Chinese hamster ovary cells.
      D H Van Leeuwen, J Eisenstein, K O'Malley and R G MacKenzie
      Molecular Pharmacology August 1995, 48 (2) 344-351;
  4. Velaz-Faircloth, M

    1. You have access
      Human brain-specific L-proline transporter: molecular cloning, functional expression, and chromosomal localization of the gene in human and mouse genomes.
      S Shafqat, M Velaz-Faircloth, V A Henzi, K D Whitney, T L Yang-Feng, M F Seldin and R T Fremeau
      Molecular Pharmacology August 1995, 48 (2) 219-229;

W

  1. Westphal, R S

    1. You have access
      Increased basal phosphorylation of the constitutively active serotonin 2C receptor accompanies agonist-mediated desensitization.
      R S Westphal, J R Backstrom and E Sanders-Bush
      Molecular Pharmacology August 1995, 48 (2) 200-205;
  2. Whetton, A D

    1. You have access
      Characterization of drug resistance mediated via the suppression of apoptosis by Abelson protein tyrosine kinase.
      R S Chapman, A D Whetton, C M Chresta and C Dive
      Molecular Pharmacology August 1995, 48 (2) 334-343;
  3. Whitney, K D

    1. You have access
      Human brain-specific L-proline transporter: molecular cloning, functional expression, and chromosomal localization of the gene in human and mouse genomes.
      S Shafqat, M Velaz-Faircloth, V A Henzi, K D Whitney, T L Yang-Feng, M F Seldin and R T Fremeau
      Molecular Pharmacology August 1995, 48 (2) 219-229;

Y

  1. Yang-Feng, T L

    1. You have access
      Human brain-specific L-proline transporter: molecular cloning, functional expression, and chromosomal localization of the gene in human and mouse genomes.
      S Shafqat, M Velaz-Faircloth, V A Henzi, K D Whitney, T L Yang-Feng, M F Seldin and R T Fremeau
      Molecular Pharmacology August 1995, 48 (2) 219-229;
Back to top
PreviousNext

In this issue

Molecular Pharmacology
Vol. 48, Issue 2
1 Aug 1995
  • Table of Contents
  • Table of Contents (PDF)
  • Index by author
  • Back Matter (PDF)
  • Editorial Board (PDF)
  • Front Matter (PDF)
Sign up for alerts
  • Most Read
Loading
  • How Many G Protein-Coupled Receptors are Drug Targets?
  • Histamine H3 Receptor
  • Cardiac Safety of Doxorubicin
  • Wnt Signaling and Drug Resistance in Cancer
  • Salicylate Blocks Lipolytic Actions of Tumor Necrosis Factor-α in Primary Rat Adipocytes
More...
Advertisement
  • Home
  • Alerts
Facebook   Twitter   LinkedIn   RSS

Navigate

  • Current Issue
  • Fast Forward by date
  • Fast Forward by section
  • Latest Articles
  • Archive
  • Search for Articles
  • Feedback
  • ASPET

More Information

  • About Molecular Pharmacology
  • Editorial Board
  • Instructions to Authors
  • Submit a Manuscript
  • Customized Alerts
  • RSS Feeds
  • Subscriptions
  • Permissions
  • Terms & Conditions of Use

ASPET's Other Journals

  • Drug Metabolism and Disposition
  • Journal of Pharmacology and Experimental Therapeutics
  • Pharmacological Reviews
  • Pharmacology Research & Perspectives
ISSN 1521-0111 (Online)

Copyright © 2022 by the American Society for Pharmacology and Experimental Therapeutics